We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Latest Articles

Helping the Pharmaceutical Industry Tackle the Evolving Challenge of Water Quality
Article

Water plays a vital role in a broad range of processes within the pharmaceutical industry, from its use as a reagent and solvent in drug synthesis, to its utilization in formulation development and analytical testing, all the way through to product packaging and labeling. As a result, pharmaceutical companies must employ a range of treatment and monitoring processes to ensure the impurities present in water do not interfere with its intended use.

READ MORE

Standardization Challenges in Pharmaceutical Product Labeling
Article

Product labels can be viewed as a “clinical instruction manual”, providing a concise description of the benefits and risks for a consumer and relevant information to dispensers, patients, and their caregivers. Here we take a look at labeling compliance, the importance of keeping information up-to-date, and risks associated with noncompliance.

READ MORE

Francis Mojica: The Modest Microbiologist Who Discovered and Named CRISPR
Article

Kicking off Technology Networks Explores the CRISPR Revolution, Professor Mojica, or "Francis", takes us on a journey back to the original research that, despite being deemed "crazy" by members of the scientific community at the time, led to the CRISPR revolution that is anticipated to edit evolution forever.

READ MORE

Who Is Responsible for Reproducible Science?
Article

Reproducibility is now recognized as a core feature of good scientific practice but too many papers fail to meet the grade. We talked to Leslie D McIntosh, CEO of Ripeta, on the topic of reproducibility. In this interview, we ask Leslie about the concepts within Ripeta’s recent report on the state of reproducible science in 2019.

READ MORE

Feeling Like a Fraud: Impostor Syndrome in STEM
Article

Impostor syndrome is experienced by millions of people around the world cross culturally, and describes difficulty internalizing one's accomplishments or abilities, and instead attributing their success to other factors. In this article, we explore the prevalence of impostor syndrome in STEM and the impact it has on the scientific community.

READ MORE

Exploring the Latest in CRISPR and Stem Cell Research
Article

Thus far, the feasibility to edit stem cells using CRISPR technology has been demonstrated in two key areas: modeling and investigating human cell states and human diseases, and regenerative medicine. In this article, we explore some of the latest research in these spaces and the approaches that scientists are adopting to overcome challenges in the field.

READ MORE

Into the Maze: Preclinical Data and The Cloud
Article

Mazes are an integral part of rodent behavioral research. In recent years, scientific data collected from maze studies have moved towards more cloud-based and electronic storage as opposed to traditional paper-based storage. In this article, we discuss modern mazes with Shuhan He, founder of maze developer MazeEngineers.com.

READ MORE

Living in the (Bio)material World: A Night at Biodesign Here Now
Article

We report the opening night of Biodesign Here Now, an event featuring architects, artists, textile designers, and many more creatives who have found ways to bring together biology and design in their work, showing a way forward for collaboration between the two fields.

READ MORE

Large Capacity Centrifuge Systems: Meeting the Cell Culture Separation Needs of the Bioprocessing Industry
Article

Large capacity centrifugation technologies are helping bioprocessing and drug discovery facilities overcome their throughput challenges by streamlining cell separation workflows and improving operational efficiency. This article looks at the benefits of using large capacity centrifuge systems, and the five factors to consider when choosing the right centrifuge system for bioprocessing workflows.

READ MORE

Anti-inflammatory Drugs Resurrected To Fight Chronic Pain
Article

Failed drugs often are left on the shelf to gather dust. But sometimes, drugs can be dusted down and repurposed. That’s exactly the route that Katexco Pharmaceuticals has taken with its new immune system-targeting compounds, part of a new life sciences company that aims to target everything from multiple sclerosis to chronic pain.

READ MORE